# OnCo record kyowa-kirin (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/kyowa-kirin/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "kyowa-kirin" ;
  schema:name "Kyowa Kirin"@en ;
  schema:description "Kyowa Kirin is a Japanese biopharmaceutical company whose oncology products include mogamulizumab (Poteligeo) for cutaneous T-cell lymphoma and toremifene (Fareston) for metastatic breast cancer."@en ;
  schema:url <https://onco.cc/companies/kyowa-kirin/>, <https://www.kyowakirin.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Kyowa_Kirin> ;
  owl:sameAs <http://www.wikidata.org/entity/Q6452254> ;
  schema:citation <https://www.kyowakirin.com> ;
  schema:addressCountry "JP" ;
  onco:targets <https://onco.cc/targets/ccr4/> ;
  onco:drugs <https://onco.cc/drugs/mogamulizumab/>, <https://onco.cc/drugs/toremifene/>, <https://onco.cc/drugs/burosumab/> ;
  onco:trials <https://onco.cc/trials/nct07629726/>, <https://onco.cc/trials/nct07623616/> .